![]() Poxel Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases. | ![]() Promethera Biosciences Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases. | ![]() MEDIAN Technologies MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. | |
Founding Date | Founding Date 2009 | Founding Date 2009 | Founding Date 2002 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Lyon, FR HQ Chiyoda City, JP Cambridge, US | Locations Mont-Saint-Guibert, BE HQ Charleroi, BE Ganshoren, BE Chuo City, JP Chuo City, JP Basel, CH Durham, US see more | Locations Valbonne, FR HQ Wuxi, CN Burlington, US |
Employees | Employees 6 | Employees 185% decrease | Employees 225 |
Valuation ($) | Valuation ($) 18.3 m | Valuation ($) N/A | Valuation ($) 76.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) €6.6m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) €23.4m (FY, 2025) |
Cost of goods | Cost of goods €2.8m (FY, 2024) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit €3.8m (FY, 2024) | Gross profit N/A | Gross profit €24.2m (FY, 2025) |
Net income | Net income (€18.3m) (FY, 2024) | Net income N/A | Net income (€34.1m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 33.8m | Total funding raised $ 146m | Total funding raised N/A |

Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases.
View company
MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice.
View company